# OKYO Pharma (OKYO) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/OKYO
## Company Profile
- Ticker: OKYO
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Ophthalmology
## Stock Data
- Close: 1.55 USD
- Market cap: 89214736.89999999 USD
- Last updated: 2026-09-03
## Business Overview
OKYO Pharma is a biotechnology company focused on inflammation, pain, and ophthalmology-related disease biology. Its programs are aimed at serious conditions where immune modulation and localized therapy matter.
## Why The Stock Is Moving

As of Sep 3, 2026, OKYO closed down 4.32% at $1.55. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, OKYO sits in specialty biotechnology.

## Business Model

The company depends on clinical data, target validation, and the ability to create a differentiated inflammation and eye-care story.

## Landscape Position

OKYO is a catalyst-sensitive specialty name whose stock is driven by early-stage progress.

## Future Catalysts

- OKYO’s catalysts are its ophthalmic-inflammatory pipeline and any update that shows the company can still build a real eye-disease story. The company remains early and data-dependent.

## Recent News
- 2026-07-28 11:00 EST — [OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer](https://biopharmsignal.com/news/OKYO/okyo-pharma-announces-purchase-of-shares-by-chief-scientific-officer-63ff975a) — Source: OKYO Pharma
- 2026-07-27 11:00 EST — [OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026](https://biopharmsignal.com/news/OKYO/okyo-pharma-to-participate-in-the-btig-biotechnology-conference-2026-75cdfd34) — Source: OKYO Pharma
- 2026-07-23 16:00 EST — [OKYO Pharma Announces Purchase of Shares by Director](https://biopharmsignal.com/news/OKYO/okyo-pharma-announces-purchase-of-shares-by-director-aba58ba0) — Source: OKYO Pharma
- 2026-07-23 11:00 EST — [OKYO Pharma Announces Purchase of Shares by Chief Executive Officer](https://biopharmsignal.com/news/OKYO/okyo-pharma-announces-purchase-of-shares-by-chief-executive-officer-c26c1c2c) — Source: OKYO Pharma
- 2026-07-22 16:00 EST — [OKYO Pharma Announces Purchase of Shares by Chairman](https://biopharmsignal.com/news/OKYO/okyo-pharma-announces-purchase-of-shares-by-chairman-991103cf) — Source: OKYO Pharma